Al-Hity, Gheed http://orcid.org/0000-0003-2011-0162
Yang, FengWei http://orcid.org/0000-0002-0619-0840
Campillo-Funollet, Eduard http://orcid.org/0000-0001-7021-1610
Greenstein, Andrew E. http://orcid.org/0000-0002-1470-1970
Hunt, Hazel http://orcid.org/0000-0002-4316-1301
Mampay, Myrthe http://orcid.org/0000-0002-4966-2721
Intabli, Haya http://orcid.org/0000-0003-3820-4431
Falcinelli, Marta http://orcid.org/0000-0001-6496-6953
Madzvamuse, Anotida http://orcid.org/0000-0002-9511-8903
Venkataraman, Chandrasekhar http://orcid.org/0000-0003-4039-2056
Flint, Melanie S. http://orcid.org/0000-0001-5311-3023
Article History
Received: 1 October 2020
Accepted: 3 June 2021
First Online: 24 June 2021
Competing interests
: All authors have no competing interest, except that Hazel Hunt and Andrew Greenstein are both Corcept stockholders.
: The experiments involving animals and Schedule 1 protocols used to obtain breast tumour tissue were approved by the Animal Welfare and Ethical Review Body (AWERB committee) of the University of Brighton. This study was conducted in accordance with the principles of the Basel Declaration and adhered to the legislation detailed in the United Kingdom Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039). All efforts were taken to maximise animal welfare conditions and to reduce the number of animals used in accordance with the European Communities Council Directive of September 20th, 2010 (2010/63/EU).